Literature DB >> 10669321

Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection.

P A Tovo1, L J Pembrey, M L Newell.   

Abstract

Data were collected from 104 infected children who were followed up from birth for a mean of 49 (range, 6-153) months in 22 European centers, to outline the natural history of perinatal hepatitis C virus (HCV) infection. Fifty-four children were persistently HCV RNA positive, 44 were occasionally positive, and 6 never had detectable viremia. At least 90% of the children had evidence of ongoing infection at the latest analysis. Eighteen children became HCV RNA negative at their last assessments, but 40% of these had high alanine aminotransferase (ALT) concentrations. Infection was asymptomatic in all but 2 children, who developed hepatomegaly. Mean ALT concentrations decreased substantially after the first 2 years of life; 14 children had persistently normal ALT values. Signs of minimal to moderate inflammation were noted in all 20 patients who underwent liver biopsy. Perinatal HCV infection is usually asymptomatic in the first years of life, but the virus persists in most children, even in the absence of elevated ALT activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669321     DOI: 10.1086/315264

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively.

Authors:  Jean-Christophe Meunier; Jens Bukh; Giacomo Diaz; Pier-Angelo Tovo; Anna Maria Casadei; Isabella Quinti; Raffaele Iorio; Suzanne Emerson; Robert H Purcell; Patrizia Farci
Journal:  J Infect Dis       Date:  2011-10-17       Impact factor: 5.226

2.  Hepatitis C viral infection in children.

Authors:  Douglas Mogul; Kathleen B Schwarz
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-07-23

3.  Spontaneous clearance of hepatitis C virus in vertically infected children.

Authors:  Susan Farmand; Stefan Wirth; Helga Löffler; Tanja Woltering; Sybille Kenzel; Elke Lainka; Philipp Henneke
Journal:  Eur J Pediatr       Date:  2011-07-07       Impact factor: 3.183

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study.

Authors:  Eskandar Hajiani; Jalal Hashemi; Rahim Masjedizadeh; Ali Akbar Shayesteh; Esmail Idani; Tahereh Rajabi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome.

Authors:  F Bortolotti; M Resti; M Marcellini; R Giacchino; G Verucchi; G Nebbia; L Zancan; M G Marazzi; C Barbera; A Maccabruni; G Zuin; G Maggiore; F Balli; P Vajro; L Lepore; M Molesini; M Guido; S Bartolacci; F Noventa
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 7.  Hepatitis C virus infection in children coinfected with HIV: epidemiology and management.

Authors:  Massimo Resti; Chiara Azzari; Flavia Bortolotti
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Treatment of hepatitis C in children: a systematic review.

Authors:  Jia Hu; Karen Doucette; Lisa Hartling; Lisa Tjosvold; Joan Robinson
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

9.  Hepatitis C virus infection in infants and children from Argentina.

Authors:  María Inés Gismondi; Estela Inés Turazza; Saúl Grinstein; María Cristina Galoppo; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.

Authors:  Melissa A Sheiko; Lucy Golden-Mason; Silvia Giugliano; Christine Waasdorp Hurtado; Cara L Mack; Michael R Narkewicz; Hugo R Rosen
Journal:  J Pediatr       Date:  2015-12-30       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.